Kwality Pharma

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE552U01010
NSEID:
BSEID: 539997

INR

1,025.00

25.6 (2.56%)

BSENSE

Dec 19

BSE+NSE Vol: 16.57 k

{
  "main_header": {
    "sid": 1002639,
    "name": "Kwality Pharma",
    "stock_name": "Kwality Pharma",
    "full_name": "Kwality Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/kwality-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,025.00",
    "chg": 25.6,
    "chgp": "2.56%",
    "dir": 1,
    "prev_price": "999.40",
    "mcapval": "1,084.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 539997,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE552U01010",
    "curr_date": "Dec 19",
    "curr_time": "",
    "bse_nse_vol": "16.57 k",
    "exc_status": "Active",
    "traded_date": "Dec 19, 2025",
    "traded_date_str": "2025 12 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/kwality-pharma-1002639-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Kwality Pharmaceuticals Sees Shift in Market Assessment Amid Strong Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kwality-pharmaceuticals-upgraded-to-buy-on-strong-financials-and-technical-momentum-3763451",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/KwalityPharmace_mojoScore_3763451.png",
        "date": "2025-12-19 08:16:12",
        "description": "Kwality Pharmaceuticals has experienced a notable revision in its market evaluation, driven by a combination of robust financial results, attractive valuation metrics, and evolving technical indicators. The company’s recent performance across key parameters highlights a nuanced outlook for investors in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Kwality Pharmaceuticals Shows Shift in Price Momentum Amid Mixed Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kwality-pharmaceuticals-shows-renewed-momentum-amid-technical-upgrades-3763386",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/KwalityPharmace_technicaldot_3763386.png",
        "date": "2025-12-19 08:10:58",
        "description": "Kwality Pharmaceuticals has exhibited a notable shift in its price momentum, transitioning from a sideways trend to a mildly bullish stance, supported by a combination of technical indicators that present a nuanced market picture. This development comes as the stock trades at ₹1,002.00, reflecting a day change of 5.17% and outperforming the broader Sensex index over multiple time frames."
      },
      {
        "title": "Kwality Pharmaceuticals Shows Mixed Technical Signals Amid Price Momentum Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kwality-pharmaceuticals-sees-technical-momentum-shift-amid-mixed-indicator-signals-3761980",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/KwalityPharmace_technicaldot_3761980.png",
        "date": "2025-12-18 08:13:20",
        "description": "Kwality Pharmaceuticals has exhibited a notable shift in its price momentum, transitioning from a mildly bearish trend to a sideways movement, reflecting a nuanced technical landscape. Recent evaluation adjustments reveal a complex interplay of technical indicators, including MACD, RSI, Bollinger Bands, and moving averages, which collectively suggest a period of consolidation for the stock amid fluctuating market conditions."
      },
      {
        "title": "Why is Kwality Pharma falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-kwality-pharma-fallingrising-3756892",
        "imagepath": "",
        "date": "2025-12-12 01:07:17",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Strong Relative Performance Against Benchmarks</strong></p>\n<p>Kwality Pharmaceuticals has demonstrated impressive returns over multiple time horizons compared to the Sensex. Over the past week, the stock surged by 7.45%, while the Sensex declined marginally by 0.52%. This outperformance extends to the one-month period, where Kwality Pharma gained 13.84% against the Sensex’s modest 1.13% rise. Year-to-date, the stock has appreciated by 9.73%, slightly ahead of the Sensex’s 8.55% increase. Even on a one-year basis, Kwality Pharma’s 9.80% gain more than doubles the Sensex’s 4.04% return. The long-term trend is even more striking, with the stock delivering a staggering 188.28% return over three years and an extraordinary 1490.33% over five years, dwarfing the Sensex’s respective 36.40% and 83.9..."
      },
      {
        "title": "Kwality Pharmaceuticals Sees Shift in Market Assessment Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kwality-pharmaceuticals-upgraded-to-hold-on-improved-technicals-and-financial-performance-3756045",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/KwalityPharmace_mojoScore_3756045.png",
        "date": "2025-12-11 08:19:17",
        "description": "Kwality Pharmaceuticals has experienced a revision in its market evaluation following a detailed analysis of its financial performance, valuation metrics, technical indicators, and overall quality parameters. The company’s recent quarterly results and long-term trends have contributed to a nuanced perspective on its investment profile within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Kwality Pharmaceuticals Shows Mixed Technical Signals Amid Price Momentum Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kwality-pharmaceuticals-shows-technical-momentum-shift-amid-mixed-market-signals-3755987",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/KwalityPharmace_technicaldot_3755987.png",
        "date": "2025-12-11 08:13:40",
        "description": "Kwality Pharmaceuticals has experienced a subtle shift in its technical landscape, reflecting a nuanced change in price momentum and market sentiment. Recent evaluation adjustments reveal a transition from a predominantly bearish stance to a mildly bearish outlook, with key indicators such as MACD, RSI, and moving averages presenting a complex picture for investors navigating the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Is Kwality Pharma technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-kwality-pharma-technically-bullish-or-bearish-3745645",
        "imagepath": "",
        "date": "2025-12-04 08:44:09",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Technical Trend Shift</strong></p>\n<p>As of 3 December 2025, Kwality Pharma’s technical trend shifted from mildly bearish to outright bearish. This change reflects growing caution among traders and technical analysts, who are observing increased selling pressure and weakening momentum. The transition to a bearish trend is significant as it signals a potential continuation of downward price movement in the near term.</p>\n<p>The daily moving averages reinforce this view, showing a bearish stance that suggests the stock is trading below key average price levels. Such a pattern often indicates that sellers are in control and that the stock may face resistance in mounting a sustained rally.</p>\n<p><strong>Technical Indicators Breakdown</strong></p>\n<p>Examining the key technical indicators..."
      },
      {
        "title": "Kwality Pharmaceuticals: Analytical Perspective Shifts Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kwality-pharmaceuticals-downgraded-to-sell-amid-technical-weakness-and-growth-concerns-3745613",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/KwalityPharmace_mojoScore_3745613.png",
        "date": "2025-12-04 08:21:33",
        "description": "Kwality Pharmaceuticals has experienced a revision in its market assessment following a detailed review of its financial performance, valuation metrics, technical indicators, and overall quality parameters. This article explores the factors influencing the recent changes in the company’s evaluation, providing investors with a comprehensive understanding of the current landscape for this Pharmaceuticals & Biotechnology stock."
      },
      {
        "title": "Kwality Pharmaceuticals Faces Bearish Momentum Amid Technical Shifts",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kwality-pharmaceuticals-faces-bearish-momentum-amid-technical-downgrade-3745511",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/KwalityPharmace_technicaldot_3745511.png",
        "date": "2025-12-04 08:11:40",
        "description": "Kwality Pharmaceuticals has experienced a notable shift in its technical momentum, with recent evaluation adjustments signalling a bearish trend across multiple timeframes. The stock’s price movement and key technical indicators suggest a cautious outlook as it navigates a challenging phase within the Pharmaceuticals & Biotechnology sector."
      }
    ],
    "total": 216,
    "sid": "1002639",
    "stock_news_url": "https://www.marketsmojo.com/news/kwality-pharmaceuticals-1002639"
  },
  "announcements": [
    {
      "caption": "Intimation Of Change In Name Of Managing Director Of The Company",
      "datetime": "01-Dec-2025",
      "details": "Intimation of Change in name of Managing Director of the Company.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "22-Nov-2025",
      "details": "Newspaper Publication of unaudited financial results for quarter and half year ended 30-09-2025",
      "source": "BSE"
    },
    {
      "caption": "Unaudited Financial Results For The Quarter And Half Year Ended 30-09-2025",
      "datetime": "13-Nov-2025",
      "details": "Unaudited Financial Results for the quarter and half year ended 30-09-2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Kwality Pharmaceuticals Ltd has declared <strong>6%</strong> dividend, ex-date: 05 Jan 17",
          "dt": "2017-01-05",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Kwality Pharmaceuticals Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 11 Oct 17",
          "dt": "2017-10-11",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Kwality Pharmaceuticals Sees Shift in Market Assessment Amid Strong Financial and Technical Signals

2025-12-19 08:16:12

Kwality Pharmaceuticals has experienced a notable revision in its market evaluation, driven by a combination of robust financial results, attractive valuation metrics, and evolving technical indicators. The company’s recent performance across key parameters highlights a nuanced outlook for investors in the Pharmaceuticals & Biotechnology sector.

Kwality Pharmaceuticals Shows Shift in Price Momentum Amid Mixed Technical Signals

2025-12-19 08:10:58

Kwality Pharmaceuticals has exhibited a notable shift in its price momentum, transitioning from a sideways trend to a mildly bullish stance, supported by a combination of technical indicators that present a nuanced market picture. This development comes as the stock trades at ₹1,002.00, reflecting a day change of 5.17% and outperforming the broader Sensex index over multiple time frames.

Kwality Pharmaceuticals Shows Mixed Technical Signals Amid Price Momentum Shift

2025-12-18 08:13:20

Kwality Pharmaceuticals has exhibited a notable shift in its price momentum, transitioning from a mildly bearish trend to a sideways movement, reflecting a nuanced technical landscape. Recent evaluation adjustments reveal a complex interplay of technical indicators, including MACD, RSI, Bollinger Bands, and moving averages, which collectively suggest a period of consolidation for the stock amid fluctuating market conditions.

Why is Kwality Pharma falling/rising?

2025-12-12 01:07:17

Strong Relative Performance Against Benchmarks

Kwality Pharmaceuticals has demonstrated impressive returns over multiple time horizons compared to the Sensex. Over the past week, the stock surged by 7.45%, while the Sensex declined marginally by 0.52%. This outperformance extends to the one-month period, where Kwality Pharma gained 13.84% against the Sensex’s modest 1.13% rise. Year-to-date, the stock has appreciated by 9.73%, slightly ahead of the Sensex’s 8.55% increase. Even on a one-year basis, Kwality Pharma’s 9.80% gain more than doubles the Sensex’s 4.04% return. The long-term trend is even more striking, with the stock delivering a staggering 188.28% return over three years and an extraordinary 1490.33% over five years, dwarfing the Sensex’s respective 36.40% and 83.9...

Kwality Pharmaceuticals Sees Shift in Market Assessment Amid Mixed Financial and Technical Signals

2025-12-11 08:19:17

Kwality Pharmaceuticals has experienced a revision in its market evaluation following a detailed analysis of its financial performance, valuation metrics, technical indicators, and overall quality parameters. The company’s recent quarterly results and long-term trends have contributed to a nuanced perspective on its investment profile within the Pharmaceuticals & Biotechnology sector.

Kwality Pharmaceuticals Shows Mixed Technical Signals Amid Price Momentum Shift

2025-12-11 08:13:40

Kwality Pharmaceuticals has experienced a subtle shift in its technical landscape, reflecting a nuanced change in price momentum and market sentiment. Recent evaluation adjustments reveal a transition from a predominantly bearish stance to a mildly bearish outlook, with key indicators such as MACD, RSI, and moving averages presenting a complex picture for investors navigating the Pharmaceuticals & Biotechnology sector.

Is Kwality Pharma technically bullish or bearish?

2025-12-04 08:44:09

Recent Technical Trend Shift

As of 3 December 2025, Kwality Pharma’s technical trend shifted from mildly bearish to outright bearish. This change reflects growing caution among traders and technical analysts, who are observing increased selling pressure and weakening momentum. The transition to a bearish trend is significant as it signals a potential continuation of downward price movement in the near term.

The daily moving averages reinforce this view, showing a bearish stance that suggests the stock is trading below key average price levels. Such a pattern often indicates that sellers are in control and that the stock may face resistance in mounting a sustained rally.

Technical Indicators Breakdown

Examining the key technical indicators...

Kwality Pharmaceuticals: Analytical Perspective Shifts Amid Mixed Financial and Technical Signals

2025-12-04 08:21:33

Kwality Pharmaceuticals has experienced a revision in its market assessment following a detailed review of its financial performance, valuation metrics, technical indicators, and overall quality parameters. This article explores the factors influencing the recent changes in the company’s evaluation, providing investors with a comprehensive understanding of the current landscape for this Pharmaceuticals & Biotechnology stock.

Kwality Pharmaceuticals Faces Bearish Momentum Amid Technical Shifts

2025-12-04 08:11:40

Kwality Pharmaceuticals has experienced a notable shift in its technical momentum, with recent evaluation adjustments signalling a bearish trend across multiple timeframes. The stock’s price movement and key technical indicators suggest a cautious outlook as it navigates a challenging phase within the Pharmaceuticals & Biotechnology sector.